المؤلفون: Sarah E. Bock, Janice Tam, George E. Sandusky, Brian S. Curran, Mary P. Hever-Jardine, Joshua M. Warzecha, Fred Kim, Michael J. Spinella, Costantine Albany, Aneeq S. Chaudhry, Katherine M. von Herrmann, Lawrence H. Einhorn, Sarah J. Freemantle, Brock C. Christensen, Leah Shin, Christina Y. Yim, Pietro Taverna

المصدر: Oncotarget

مصطلحات موضوعية: embryonal carcinoma, Male, 0301 basic medicine, Somatic cell, DNA Methyltransferase Inhibitor, Antineoplastic Agents, Mice, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Testicular Neoplasms, Cell Line, Tumor, medicine, Animals, Humans, DNA (Cytosine-5-)-Methyltransferases, Testicular cancer, Cisplatin, DNA methylation, business.industry, Gene Expression Profiling, Neoplasms, Germ Cell and Embryonal, medicine.disease, Xenograft Model Antitumor Assays, testicular cancer, Demethylating agent, Gene Expression Regulation, Neoplastic, in vivo, 030104 developmental biology, Oncology, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, SGI-110, Immunology, Azacitidine, Cancer research, Tumor Suppressor Protein p53, Stem cell, business, Reprogramming, Research Paper, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03ed0ac8bf2d8b824d7fe746d0e7178
https://doi.org/10.18632/oncotarget.13811